Annual report pursuant to Section 13 and 15(d)

Note 2 - Acquisitions (Tables)

v3.2.0.727
Note 2 - Acquisitions (Tables)
12 Months Ended
Jun. 30, 2015
Notes Tables  
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]
 
 
Novus
 
 
Protein
-
Simple
 
 
CyVek
 
 
Bionostics
 
 
PrimeGene
 
                                         
Current assets
  $ 10,739     $ 19,660     $ 1,206     $ 9,605     $ 1,272  
Equipment
    1,266       1,983       971       2,180       546  
Other long-term assets
    40       554       19                  
Intangible Assets:
                                       
Developed technology
    5,010       39,200       20,200       14,400       2,200  
Trade name
    5,300       36,100       100       2,700       3,000  
Customer relationships
    14,400       101,600       600       41,000       9,100  
Non-compete agreements
    -       200       -        2,400        322  
Goodwill
    28,408       134,074       91,658       56,349       5.518  
Total assets acquired
    65,163       333,371       114,754       128,634       21,958  
                                         
Liabilities
    2,166       11,644       1,965       3,007       887  
Deferred income taxes, net
    2,875       21,674       (438 )     22,478       2,310  
Net assets
  $ 60,122     $ 300,053     $ 113,327     $ 103,149     $ 18,761  
Less fair-value of previous investment
    -       -       18,300       -       -  
Net assets acquired
    60,122       300,053       94,927       103,149       18,761  
                                         
Cash paid, net of cash acquired
  $ 60,122     $ 300,053     $ 59,927     $ 103,149     $ 6,031  
Contingent consideration payable
    -       -       35,000       -       12,730  
Net purchase price
  $ 60,122     $ 300,053     $ 94,927     $ 103,149     $ 18,761  
Condensed Income Statement [Table Text Block]
 
 
Novus
 
 
Protein
-
Simple
 
 
CyVek
 
                         
Net sales
  $ 21,092     $ 65,512     $ 735  
Net income (loss)
    (610
)
    (3,624
)
    (4,196
)
Amortization expense
    1,898       11,364       981  
Costs recognized on sale of acquired inventory
    1,946       1,444       64  
Business Acquisition, Pro Forma Information [Table Text Block]
 
 
For the Year Ended June, 30
 
 
 
2015
 
 
2014
 
                 
Net sales
  $ 457,270     $ 433,034  
Net income
    104,132       100,958